HETERO LABS LIMITED

Location

Telangana

Founded

1989-03-10

Risk Signals

263 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about HETERO LABS LIMITED

Live alerts from global media, monitored by Business Radar

Hetero Labs Gets CDSCO Panel Nod To Study Antipsychotic Drug Brexpiprazole Tablets

2025-02-22 (medicaldialogues.in)

Hetero Labs Gets CDSCO Panel Nod To Study Antipsychotic Drug Brexpiprazole Tablets

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to Hetero Labs for conducting a bioequivalence study (BE) of...

Read more
Require Regulatory Affairs Specialist at Hetero Labs Limited - M.Pharm, B.Pharm, MSc Apply

2024-09-26 (pharmatutor.org)

Require Regulatory Affairs Specialist at Hetero Labs Limited - M.Pharm, B.Pharm, MSc Apply

Prepare and compile DMFs in compliance with regulations for regulatory and semi-regulatory countries. Provide necessary documentation support to the Marketing department.

Read more
Justify proposed dosage and high strength with data: CDSCO Panel Tells Hetero Healthcare on Tioconazole vaginal film 300 mg

2024-09-02 (medicaldialogues.in)

Justify proposed dosage and high strength with data: CDSCO Panel Tells Hetero Healthcare on Tioconazole vaginal film 300 mg

New Delhi: Noting Tioconazole Vaginal Film 300mg is not approved anywhere in the world, the Subject Expert Committee SEC functional under the Central Drug Standard Control Organisation (CDSCO) has...

Read more
Hetero Labs Gets CDSCO Panel Nod To Study Antibiotic Tebipenem Pivoxil Dispersible Tablet

(medicaldialogues.in)

Hetero Labs Gets CDSCO Panel Nod To Study Antibiotic Tebipenem Pivoxil Dispersible Tablet

New Delhi: Stating that the decision to waive off the clinical trial will be taken after a review of the Bioequivalence study report, the Subject Expert Committee (SEC) functional under Central Drug...

Read more
Hetero Lab Gets CDSCO Panel Nod To Study Pregabalin, Polmacoxib FDC tablet

(medicaldialogues.in)

Hetero Lab Gets CDSCO Panel Nod To Study Pregabalin, Polmacoxib FDC tablet

New Delhi: The drug major Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to conduct a bioequivalence (BE)...

Read more

Never miss a headline about HETERO LABS LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages